Health Care/Hospital
Fangzhou Inc. and Bristol Myers Squibb China Join Forces on a Strategic Alliance to Advance Internet Healthcare
SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a pioneer in Internet healthcare solutions, announced a strategic alliance with Bristol Myers Squibb ("BMS")China on December 16th. The partnership was officially formalized with the signing of a colla...
2024-12-19 12:40
1015
Caliway to Present CBL-514 Phase 2b Study Results for Subcutaneous Fat Reduction at IMCAS 2025 in Paris
* The findings from the CBL-0204 Phase 2b clinical trial have been selected for presentation at IMCAS, the premier global congress in aesthetic medicine. The data will be highlighted in both the 2025 focus session on advances in fat reduction therapies and further detailed in the Non-surgical B...
2024-12-19 10:47
1104
Pharus Diagnostics LLC Announces Validation of a Laboratory-Developed Test for Early Pancreatic Cancer Detection
LOS ANGELES, Dec. 19, 2024 /PRNewswire/ -- Pharus Diagnostics LLC. (PharusDx), an innovator in non-invasive diagnostic tests, today announced a significant step forward in the fight against pancreatic cancer. The company is announcing availability of its OncoSweep™ Pancreas Spotlight, a liquid bi...
2024-12-19 01:00
1825
Clarity expands its pipeline with a novel optimised FAP-targeted radiopharmaceutical
Highlights * Clarity has developed a proprietary fibroblast activation protein (FAP)-targeted radiopharmaceutical product that can be used with the perfect pairing of copper isotopes for the diagnosis and treatment of cancer. * The product, termed SAR-bisFAP, has shown strong tumour targeting...
2024-12-18 22:03
1354
DNAnexus Recognized by Frost & Sullivan for Ability to Integrate and Synchronize Diverse Clinical and Multi-omics Data
Leading cloud-based enterprise platform for precision health data empowers biopharma companies with actionable insights to accelerate drug discovery and development SAN ANTONIO, Dec. 18, 2024 /PRNewswire/ -- Frost & Sullivan researched the bioinformatics-based drug discovery and development ...
2024-12-18 22:00
1096
Boryung Announces Winners of the 3rd Humans In Space Challenge
Paving the Way as a Global Leader in Space Healthcare - Introducing of a new funding model to support space experiments and strengthen research in space healthcare - Hosted the final round of the Humans In Space Challenge at the 75th International Astronautical Congress SEOUL, South Korea, Dec....
2024-12-18 22:00
1362
Ascletis Announces ASC47, a Muscle-Preserving Weight Loss Drug Candidate for Treatment of Obesity, in Combination with Semaglutide, Demonstrated Superior Weight Loss to Semaglutide Monotherapy in a Preclinical Model
* In a head-to-head diet-induced obese (DIO) mouse study, ASC47 low dose combination 1 (ASC47, 3 mg/kg, subcutaneous(SQ), once every four weeks plus semaglutide, 30 nmol/kg, SQ, once daily), demonstrated superior weight loss compared to semaglutide monotherapy (30 nmol/kg, SQ, once daily), show...
2024-12-18 21:43
2101
Juncell Therapeutics Opens State-of-the-Art Facility for TIL Production
SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Shanghai Juncell Therapeutics Co., Ltd. (Juncell Therapeutics), a clinical-stage biotech focused on innovative IL-2-independent Tumor-Infiltrating Lymphocyte (TIL) therapies, announced the grand opening of its state-of-the-art TIL manufacturing facility loc...
2024-12-18 21:08
1212
Apollo Care Secures Growth Equity Investment from Flexpoint Ford to Accelerate Patient Access and Commercial Solutions Initiatives
* Strategic investment from Flexpoint Ford to drive Apollo Care's growth initiatives * Proceeds will be used to expand Apollo Care's innovation pipeline, enhance existing technology, and scale operations * Flexpoint Ford's Jonathan Oka and Elliot Lauzen join Apollo Care's Board of Director...
2024-12-18 21:00
1254
Gan & Lee Pharmaceuticals Announces U.S. FDA Clearance of the IND application for the innovative Bi-weekly GLP-1RA GZR18 Injection, Bofanglutide, with chronic weight management Indication (A Phase 2 head-to-head with Tirzepatide clinical trial)
BEIJING and BRIDGEWATER, N.J., Dec. 18, 2024 /PRNewswire/ -- Gan & Lee Pharmaceuticals (Gan & Lee, Shanghai Stock Exchange: 603087.SH), is pleased to announce that the Food and Drug Administration (" FDA ") has cleared the Investigational New Drug (IND) application for GZR18 Injection to conduct ...
2024-12-18 19:34
2254
Tokyo Lifestyle Co., Ltd. Reports First Six Months of Fiscal Year 2025 Financial Results
TOKYO, Dec. 18, 2024 /PRNewswire/ -- Tokyo Lifestyle Co., Ltd. ("Tokyo Lifestyle" or the "Company") (Nasdaq: TKLF), a retailer and wholesaler of Japanese beauty and health products, sundry products, luxury products, electronic products, as well as other products in Hong Kong, Japan, North Americ...
2024-12-18 19:00
1270
Ayala Corporation partners with ING to secure sustainable finance €50 million, advancing healthcare growth in the Philippines
MANILA, Philippines, Dec. 18, 2024 /PRNewswire/ -- Ayala Corporation signed a
€50 million (₱3.1 Billion) social loan from leading European bank ING to
support AC Health's portfolio growth.
2024-12-18 17:46
1865
Xinhua Silk Road: Evaluation report highlights Seoul 120 hotline for its efficient operation
BEIJING, Dec. 18, 2024 /PRNewswire/ -- Seoul 120 hotline has contributed to
efficient city operation, according to the Evaluation Report on Worldwide City
Hotline Services and Governance Effectiveness (2024) released on Wednesday.
2024-12-18 16:14
1232
Samsung invests in Generate: Biomedicines to advance AI-driven protein therapeutics discovery
- Samsung Life Science Fund invests in Generate:Biomedicines, a Flagship Pioneering company leading in AI-enabled protein therapeutics discovery and development - Investment highlights Samsung's dedication to advancing innovation and creating a robust ecosystem for AI-enabled therapeutic develop...
2024-12-18 13:09
1655
U.S. FDA approves Celltrion's STEQEYMA® (ustekinumab-stba), a biosimilar to STELARA® (ustekinumab)
* STEQEYMA (CT-P43) is approved for both adult and pediatric patients with plaque psoriasis (PsO) and active psoriatic arthritis (PsA) as well as adults with Crohn's disease (CD) and ulcerative colitis (UC) * STEQEYMA is a strategic addition to Celltrion's portfolio, expanding the portfolio a...
2024-12-18 11:50
878
Fosun International Awarded TVB's Highest Honor "Outstanding ESG Award"
HONG KONG, Dec. 18, 2024 /PRNewswire/ -- On 13 December 2024, the "TVB ESG Awards" ceremony, hosted by Television Broadcasts Limited (hereinafter referred to as "TVB"), was held at the Hong Kong Convention and Exhibition Centre. Fosun International was honored with the highest accolade, the "Outs...
2024-12-18 11:43
1583
TPIsoftware Expedites Underwriting and Claims Processing for Cathay Life Insurance
TAIPEI, Dec. 18, 2024 /PRNewswire/ -- As a leading expert in Fintech and Insurtech, TPIsoftware has once showcased its digital expertise in delivering tech-driven solutions for Cathay Life Insurance. With Cathay utilizing TPIsoftware's Business Process Management (BPM) platform digiFlexis and dig...
2024-12-18 11:10
1217
Neurizon Files IND Application to Support HEALEY ALS Platform Trial
Highlights: * IND application submission to the U.S. Food and Drug Administration (FDA) is a pivotal step in initiating a Phase 2/3 clinical study for NUZ-001 * The IND is a comprehensive dossier of information, including animal and human studies, pharmacokinetic analyses, toxicology studies,...
2024-12-18 10:59
1604
Nutiani Unveils Top Five Consumer Trends for 2025
TOKYO, Dec. 18, 2024 /PRNewswire/ -- Nutrition science solutions brand Nutiani recently announced its top five consumer trends for 2025 in its live Health & Nutrition Trends Webcast. Presented byRebecca Cuthbertson, Head of Marketing, Advanced Nutrition, Fonterra, and Pooja Passi, Head of Insight...
2024-12-18 09:00
1965
Everest Medicines Announces the First Prescription of VELSIPITY® in the Greater Bay Area, Officially Benefiting Mainland China Patients
SHANGHAI, Dec. 18, 2024 /PRNewswire/ -- Everest Medicines (HKEX 1952.HK, "Everest", or the "Company"), a biopharmaceutical company focused on the discovery, clinical development, manufacturing and commercialization of innovative therapeutics, today announced that the first prescription for VELSI...
2024-12-18 08:00
1388
Week's Top Stories
Most Reposted
PARKROYAL COLLECTION MARINA BAY IS THE FIRST HOTEL IN SINGAPORE TO ATTAIN THREE PRESTIGIOUS SUSTAINABILITY CERTIFICATIONS
[Picked up by 323 media titles]
2024-12-19 13:41
Mayapada Hospitality Holding Open the first voco Hotel in Indonesia.
[Picked up by 309 media titles]
2024-12-20 16:25
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
[Picked up by 308 media titles]
2024-12-19 17:56
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
[Picked up by 306 media titles]
2024-12-20 18:11
XTransfer and OCBC Jointly Announce Comprehensive Partnership
[Picked up by 263 media titles]
2024-12-23 17:36
Most Read
AI and Cyber Security Dominate ASEAN Enterprises' Digital Transformation Priorities
2024-12-20 18:11
9425
Magic Compass Group Sponsors 2024 World Taekwondo Poomsae Championship
2024-12-19 17:56
9076
